top of page

biologit News

Nicole Baker shortlisted for the Fifth AI Awards Ireland 2023

Nicole Baker shortlisted for the Fifth AI Awards Ireland 2023

Biologit is proud to share that our CEO, Nicole Baker, is one of the four finalists in the "Woman AI Person of the Year" category for the 2023 annual AI Awards, sponsored by AI Ireland, taking place November, 21st in Dublin.

Biologit at DIA Japan November 2023

Biologit at DIA Japan November 2023

DIA Japan Annual Meeting 2023 is unique in presenting the entire healthcare value chain ranging from policy and regulations to R&D, marketing and access.

Held over three days under the theme of “Rebuilding Drug Development through Society 5.0", this edition of DIA represents a unique forum where every stakeholder is invited to discuss with their peers the future of drug development by combining the knowledge and skills of past, present, and future.

Connect with our team at the event 👇

Biologit CEO Shortlisted for Annual Technology Ireland Awards 2023

Biologit CEO Shortlisted for Annual Technology Ireland Awards 2023

Biologit's CEO, Nicole Baker has been announced as a finalist for the Annual Technology Ireland 2023 in the category "Women in Tech Initiative of the Year." The winners will be revealed during the Technology Ireland Awards Ceremony on November 17th in Dublin.

Biologit shortlisted for KPMG Global Tech Innovator Awards

Biologit shortlisted for KPMG Global Tech Innovator Awards

Biologit was shortlisted as one of only eight tech startups from Ireland in the KPMG Global Tech Innovator award. Co-founder Bruno Ohana discusses the vision and benefits of AI in pharmacovigilance at the KPMG global tech innovators event.

Biologit co-founders join the dots to screen data for risks

Biologit co-founders join the dots to screen data for risks

From the Sunday Business Post: biologit, the AI-focused business which covers the pharma, medical devices, cosmetic and animal product sectors has recently completed a round of fundraising and is now focused on growth and development.

bottom of page